Global Leukapheresis Devices Market– Driver
Increasing incidence of leukemia
Increasing incidence of leukemia is expected to propel growth of the global leukapheresis devices market over the forecast period. For instance, according to the Leukemia and Lymphoma Society (2020), every 3 minutes, one person in the U.S. is diagnosed with blood cancer. According to the North American Association of Central Cancer Registries (NAACCR), in 2022, the country is estimated to record 6,660 cases of acute lymphocytic leukemia. According to the American Cancer Society, 60,530 were diagnosed with leukemia in 2020.
Increasing number of blood donations
Increasing number of blood donations can also drive the leukapheresis devices market growth. For instance, according to an article published in World Health Orgnisation in June 2023, reported 79 countries collect over 90% of its blood supply from voluntary unpaid blood donors; however, 54 countries collect more than 50% of its blood supply from family/replacement globally.
High cost associated with apheresis procedure and devices
High cost associated with apheresis procedure and devices are major factors that hinder growth of the market. For instance, in the U.S., the cost of an apheresis procedure is around US$ 2,500 per treatment, which is very high. Furthermore, in India, the apheresis machine costs US$ 23,459 and there is an apheresis kit, which is required for separating components costing around US$ 134, which is very costly for low-income individuals to afford.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients